Skip to main content
OpenTrials

Clinical trial condition

Leukemia, Lymphoblastic, Acute, Philadelphia-Positive

Explore clinical trials studying Leukemia, Lymphoblastic, Acute, Philadelphia-Positive. Study availability and eligibility vary by location and protocol.

7 public trials 3 recruiting studies
Refine in advanced search Browse all conditions

Leukemia, Lymphoblastic, Acute, Philadelphia-Positive trial results

Recruiting

Study for Safety and Efficacy of Olverembatinib Combined With APG-2575 in Children With Relapsed/Refractory Ph + ALL

NCT05495035

Conditions
Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +12 more
Locations
  • The Second Affiliated Hospital of Anhui Medical University Hefei, Anhui, China
  • Qilu Hospital of Shandong University Jinan, Shandong, China
  • Department of Pediatrics, Institute of Hematology and Blood Disease Hospital, Chinese Academy of Medical Sciences Tianjin, Tianjin Municipality, China
  • Department of Hematology/Oncology, Shanghai Jiaotong University School of Medicine Affiliated Shanghai Children's Medical Center Shanghai, China
View Trial Details
Recruiting

A Study of Olverembatinib in Patients With Newly Diagnosed Ph+ ALL (POLARIS-1)

NCT06051409

Conditions
Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +10 more
Locations
  • Ascentage Investigative Site #1044 Birmingham, Alabama, United States
  • Ascentage Investigative Site #1062 Duarte, California, United States
  • Ascentage Investigative Site #1134 Los Angeles, California, United States
  • Ascentage Investigative Site #1059 Los Angeles, California, United States
View all 90 locations
View Trial Details
Completed

Advanced Chronic Myelogenous Leukemia (CML) - Follow On: Study of BMS-354825 in Subjects With CML

NCT00123487

Conditions
Bone Marrow Diseases, Chronic Disease, Disease Attributes, +19 more
Locations
  • University Of Alabama At Birmingham Birmingham, Alabama, United States
  • Loma Linda University Cancer Center Loma Linda, California, United States
  • Ucla Dept. Of Medicine Los Angeles, California, United States
  • Washington Cancer Institute At Washington Hospital Center Washington D.C., District of Columbia, United States
View all 119 locations
View Trial Details
Completed

Dasatinib (BMS-354825) in Subjects With Lymphoid Blast Phase Chronic Myeloid Leukemia or Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia

NCT00101595

Conditions
Bone Marrow Diseases, Chronic Disease, Chronic Myeloid Leukemia, +18 more
Locations
  • Local Institution Birmingham, Alabama, United States
  • Local Institution Anaheim, California, United States
  • Local Institution Los Angeles, California, United States
  • Local Institution Stanford, California, United States
View all 60 locations
View Trial Details

Related conditions